Prevalence of diminished ovarian reserve in Chinese women with follicular cysts and menstrual disorders

Gynecol Endocrinol. 2023 Aug 18;39(1):2250004. doi: 10.1080/09513590.2023.2250004.

Abstract

Objectives: To assess the prevalence of diminished ovarian reserve (DOR) in Chinese women with follicular cysts and menstrual disorders and relationship to hormonal markers.

Methods: 117 women with follicular cysts and menstrual disorders, aged 24 ∼ 53 (39.19 ± 6.61) years; measurements of height, weight, follicle-stimulating hormone (FSH), luteinizing hormone (LH), E2, progesterone (Po), prolactin (PRL), total testosterone, AMH, follicular cyst diameter, endometrial thickness. Three age groups were compared: 1) 21 ∼ 30 years, 2) 30 ∼ 40 years, 3) > 40 years.

Results: Total prevalence of DOR 86.3%, in the groups 50%, 81.6%, and 98.4%, in group-3 significantly higher than in group-1 and 2. 34.2% of the 117 patients complained of cessation of regular menstruations or amenorrhea, 65.8% of abnormal uterine bleeding. Follicular cysts disappeard in cycle-1 for 98 (83.8%) and in cycle-2 for 117 (100%) patients. AMH decreased with age, significantly different between the three groups. Total testosterone in group-1 and 2 was significantly higher than in group-3. In total AMH had a negative correlation with age and E2 (p < 0.01) and positive correlation with total testosterone (p < 0.05).

Conclusions: Assessing ovarian reserve with follicular cysts and menstrual disorders is important because often pointing to DOR. The overall prevalence of DOR was high; even young women (<40 years) with follicular cysts and menstrual disorders had a low level of AMH. So AMH can be used as a marker to define DOR with higher sensitivity than other markers like FSH and E2. Primarily, these results only apply to Chinese women and should be confirmed in further studies.

Keywords: Diminished ovarian reserve; anti-müllerian hormone; follicular cyst; functional ovarian cyst; menstrual disorders.

MeSH terms

  • East Asian People
  • Female
  • Follicle Stimulating Hormone, Human
  • Follicular Cyst*
  • Humans
  • Menstruation Disturbances / complications
  • Menstruation Disturbances / epidemiology
  • Ovarian Diseases*
  • Ovarian Reserve*
  • Prevalence
  • Testosterone

Substances

  • Follicle Stimulating Hormone, Human
  • Testosterone